Trials / Completed
CompletedNCT02480972
Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging
Hepatic Fibrosis Assessment Using Multiparametric Magnetic Resonance Imaging (MRI)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 69 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess degree of hepatic fibrosis using multiparametric MRI for investigating difference between normal or early fibrosis and advanced fibrosis.
Detailed description
In patients with liver parenchymal disease or normal liver parenchyma who are scheduled to undergo either liver resection or liver biopsy are included. Referred patients undergo multiparametric MRI including perfusion, diffusion, elastography and fat quantification before surgery or biopsy. The pathophysiologic changes are evaluated using multiparametric MRI, and compared between normal/early fibrosis and advanced fibrosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | magnetic resonance imaging | multiparametric MRI as follows: 1. diffusion weighted imaging using multiple b-values 2. Fat quantification sequence 3. perfusion MRI using ECCM agent 4. MR elastography \------------------------------------ 5. routine MRI using hepatocyte specific agent (optional in patients with focal liver lesion) |
Timeline
- Start date
- 2015-06-23
- Primary completion
- 2016-09-20
- Completion
- 2020-08-28
- First posted
- 2015-06-25
- Last updated
- 2021-12-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02480972. Inclusion in this directory is not an endorsement.